People living with #schizophrenia deserve more, and today we’re proud to announce the FDA approval of the first new mechanism of action to treat schizophrenia in more than 30 years. Board Chair and CEO Chris Boerner speaks on the significance of today’s historic FDA approval, marking a new chapter in care and a demonstration of our commitment to the field of neuropsychiatry. It’s time we change the conversation around serious mental illness and what it means to live with schizophrenia. Learn more: https://bit.ly/4gRqVtE
Bristol Myers Squibb
Pharmaceutical Manufacturing
Lawrence Township, NJ 1,470,250 followers
About us
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
- Website
-
http://www.bms.com
External link for Bristol Myers Squibb
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Lawrence Township, NJ
- Type
- Public Company
- Specialties
- biotechnology, innovation, great place to work, pharmaceuticals, research and development, and healthcare
Locations
Employees at Bristol Myers Squibb
-
Bill Trebasky
Biopharmaceuticals Operations Executive
-
Mark Kaplan
Senior Director Translational Oncology
-
Lisa Filaferro, MBA, PHR
-
Lakshman Nagesh Yerramalla
PMO Executive Leader & Transformations Specialist ⇨ PMO Strategy & Optimization | Business Transformation Leadership | Strategic Portfolio Management…
Updates
-
Today, the U.S. FDA approved a new treatment for #schizophrenia in adults, representing the first new class of medicine for treating schizophrenia in several decades. This landmark approval marks a new chapter in the treatment landscape for the schizophrenia community. We remain focused in our pursuit to deliver transformative therapeutic options to patients in need. Read more: https://bit.ly/3XKKE5t
-
Patients are our “why” and our Global Patient Advocacy team is part of the “how.” This #GlobalPatientWeek, hear from our VP of Global Patient Outreach, Jasmine Greenamyer, on how the team prioritizes the patient perspective in our decisions, including our global program offering education and resources to cardiomyopathy patients in 12 countries: https://bit.ly/3MYwLvx #OneBMS
-
As a senior scientist working on autoimmune diseases, our colleague Jola loves working in the lab. But living with rheumatoid arthritis (RA) impacts tasks that require her hands, like gardening. Learn how she’s navigating life as an RA patient at work with support from her supervisors: https://bit.ly/47EdAk5 #GlobalPatientWeek #OneBMS
-
As part of our commitment to advancing care for the psoriasis community, we’re researching oral agents with a goal to bring symptom relief to people living with scalp #psoriasis. Though most individuals with psoriasis experience flareups on the scalp, there has been limited research on effective oral therapeutic options. Learn more: https://bit.ly/4d4ScFz #EADVCongress
-
“Please keep forging ahead and pushing the boundaries of science.” Patients like Yuetong are why we’re dedicated to advancing medical breakthroughs. See his #GlobalPatientWeek story of living with beta thalassemia, a blood disorder that can require burdensome transfusions and sap or drain energy. Watch more to see how he’s facing the future with hope: https://bit.ly/3ZFUoAl #GlobalPatientWeek #OneBMS
-
The work we do for patients can even touch the lives of our own loved ones. Discover who inspires our colleague Claire and join us as we reflect on our commitment to patients during #GlobalPatientWeek: https://bit.ly/4gxiGTr #OneBMS
-
Looking forward to seeing you at the BMS-sponsored satellite symposium, Role of Immune Strategies in Consolidation and Maintenance at #IMS2024. Learn more about the symposium: https://bit.ly/3zti94b
-
After Emilia’s cancer diagnosis, early detection, proactive health management and the support of her family helped her return to her favorite pastime: rowing. Hear her moving #GlobalPatientWeek story here: https://bit.ly/4gGqySn #OneBMS
Affiliated pages
Similar pages
Browse jobs
Stock
BMY
NYSE
20 minutes delay
$50.12
0.17 (0.34%)
- Open
- 49.82
- Low
- 49.715
- High
- 50.55
Data from Refinitiv
See more info on